Diabetic polyneuropathy in controlled clinical trials: Consensus report of the peripheral nerve society
Peripheral Nerve Society
The subject of this report was discussed at a special session of the Annual Meeting of the Peripheral Nerve Society in St. Paul, Minnesota, on June 16, 1994. Attendees were invited to participate in modifying the report and in naming others who should be asked to participate. The report was sent to contributors (up to six times), who modified it and signed that they had read and agreed with the final report. See Appendix for complete list of contributors.
Search for more papers by this authorPeripheral Nerve Society
The subject of this report was discussed at a special session of the Annual Meeting of the Peripheral Nerve Society in St. Paul, Minnesota, on June 16, 1994. Attendees were invited to participate in modifying the report and in naming others who should be asked to participate. The report was sent to contributors (up to six times), who modified it and signed that they had read and agreed with the final report. See Appendix for complete list of contributors.
Search for more papers by this author
References
- 1
Dyck PJ,
O'Brien P.
Peripheral neuropathy.
In: RJ Porter,
BS Schoenberg, eds.
Controlled clinical trials in neurological disease.
Boston: Kluwer Academic,
1990:
203–224
10.1007/978-1-4613-1495-0_16 Google Scholar
- 2
Dyck PJ,
O'Brien PC.
Meaningful degrees of prevention or improvement of nerve conduction in controlled clinical trials of diabetic neuropathy.
Diabetes Care
1989;
12:
649–652
10.1002/mus.880110106 Google Scholar
- 3 Dyck PJ, Bushek W, Spring EM, et al. Vibratory and cooling detection thresholds compared with other tests in diagnosing and staging diabetic neuropathy. Diabetes Care 1987; 10: 432–440
- 4 Dyck PJ, Kratz KM, Lehman KA, et al. The Rochester Diabetic Neuropathy Study: design, criteria for types of neuropathy, selection bias, and reproducibility of neuropathic tests. Neurology 1991; 41: 799–807
- 5 Report and recommendations of the San Antonio Conference on Diabetic Neuropathy. Consensus statement. Diabetes 1988; 37: 1000–1004
- 6 Proceedings of a consensus development conference on standardized measures in diabetic neuropathy. Diabetes Care 1992; 15: 1080–1083
- 7 Sima AA, Bril V, Nathaniel V, et al. Regeneration and repair of myelinated fibers in sural nerve biopsy specimens from patients with diabetic neuropathy treated with sorbinil. N Engl J Med 1988; 319: 548–555
- 8 Dyck PJ, Zimmerman BR, Vilen TH, et al. Nerve glucose, fructose, sorbitol, myo-inositol, and fiber degeneration and regeneration in diabetic neuropathy. N Engl J Med 1988; 319: 542–548
- 9 Young MJ, Breddy JL, Veves A, Boulton AJM. The prediction of diabetic neuropathic foot ulcerations using vibration perception thresholds: a prospective study. Diabetes Care 1994; 17: 557–561
- 10 Thomas PK, Tomlinson DR. Diabetic and hypoglycemic neuropathy. In: PJ Dyck, PK Thomas, JW Griffin, et al, eds. Peripheral neuropathy. Philadelphia: WB Saunders, 1993: 1219–1250
- 11 Dyck PJ, Thomas PK, Asbury AK, et al. Diabetic neuropathy. Philadelphia: WB Saunders, 1987
- 12 Asbury AK. Proximal diabetic neuropathy. Ann Neurol 1977; 2: 179–190
- 13 Dyck PJ, Lais A, Karnes JL, et al. Fiber loss is primary and multifocal in sural nerves in diabetic polyneuropathy. Ann Neurol 1986; 19: 425–439
- 14 Archer AG, Watkins PJ, Thomas PK, et al. The natural history of acute painful neuropathy in diabetes mellitus. J Neurol Neurosurg Psychiatry 1983; 46: 491–499
- 15 Kennedy WR, Navarro X, Goetz FC, et al. Effects of pancreatic transplantation on diabetic neuropathy. N Engl J Med 1990; 322: 1031–1037
- 16 Jakobsen J, Christiansen JS, Kristoffersen I, et al. Autonomic and somatosensory nerve function after 2 years of continuous subcutaneous insulin infusion in type I diabetes. Diabetes 1988; 37: 452–455
- 17 Dyck PJ, Lambert EH, Windebank AJ, et al. Acute hyperosmolar hyperglycemia causes axonal shrinkage and reduced nerve conduction velocity. Exp Neurol 1981; 71: 507–514
- 18 Orskov L, Worm M, Schmitz O, et al. Nerve conduction velocity in man: influence of glucose, somatostatin and electrolytes. Diabetologia 1994; 37: 1216–1220
- 19 Lambert EH, Dyck PJ. Compound action potentials of sural nerve in vitro in peripheral neuropathy. In: PJ Dyck, PK Thomas, JW Griffin, eds. Peripheral neuropathy. Philadelphia: WB Saunders, 1993: 672–684
- 20 O'Brien PC. Procedures for comparing samples with multiple endpoints. Biometrics 1984; 40: 1079–1087
Citing Literature
